Tempo Scan Pacific
Market Cap
Rp6.9t
Last Updated
2021/05/09 17:07 UTC
Data Sources
Company Financials
Executive Summary
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Undervalued with solid track record.
Similar Companies
Share Price & News
How has Tempo Scan Pacific's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TSPC is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: TSPC's weekly volatility (3%) has been stable over the past year.
Market Performance
7 Day Return
0.7%
TSPC
1.3%
ID Pharmaceuticals
-0.5%
ID Market
1 Year Return
27.5%
TSPC
20.4%
ID Pharmaceuticals
22.3%
ID Market
Return vs Industry: TSPC exceeded the ID Pharmaceuticals industry which returned 19.3% over the past year.
Return vs Market: TSPC exceeded the ID Market which returned 23.4% over the past year.
Shareholder returns
| TSPC | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.7% | 1.3% | -0.5% |
| 30 Day | -4.7% | -3.8% | -2.7% |
| 90 Day | 1.7% | -9.1% | -5.5% |
| 1 Year | 32.2%27.5% | 22.7%20.4% | 26.3%22.3% |
| 3 Year | 5.9%-2.9% | 2.3%-3.3% | 2.3%-5.4% |
| 5 Year | -10.4%-22.1% | 32.9%20.3% | 34.1%17.8% |
Long-Term Price Volatility Vs. Market
How volatile is Tempo Scan Pacific's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Tempo Scan Pacific undervalued compared to its fair value and its price relative to the market?
49.6%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TSPC (IDR1530) is trading below our estimate of fair value (IDR3033.49)
Significantly Below Fair Value: TSPC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TSPC is good value based on its PE Ratio (8.7x) compared to the ID Pharmaceuticals industry average (25x).
PE vs Market: TSPC is good value based on its PE Ratio (8.7x) compared to the ID market (22.3x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TSPC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TSPC is good value based on its PB Ratio (1.1x) compared to the ID Pharmaceuticals industry average (2.4x).
Future Growth
How is Tempo Scan Pacific forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
18.4%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tempo Scan Pacific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Tempo Scan Pacific performed over the past 5 years?
5.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TSPC has high quality earnings.
Growing Profit Margin: TSPC's current net profit margins (7.2%) are higher than last year (5%).
Past Earnings Growth Analysis
Earnings Trend: TSPC's earnings have grown by 5.4% per year over the past 5 years.
Accelerating Growth: TSPC's earnings growth over the past year (41.9%) exceeds its 5-year average (5.4% per year).
Earnings vs Industry: TSPC earnings growth over the past year (41.9%) exceeded the Pharmaceuticals industry 9%.
Return on Equity
High ROE: TSPC's Return on Equity (13.1%) is considered low.
Financial Health
How is Tempo Scan Pacific's financial position?
Financial Position Analysis
Short Term Liabilities: TSPC's short term assets (IDR5,941.1B) exceed its short term liabilities (IDR2,008.0B).
Long Term Liabilities: TSPC's short term assets (IDR5,941.1B) exceed its long term liabilities (IDR719.4B).
Debt to Equity History and Analysis
Debt Level: TSPC's debt to equity ratio (10.3%) is considered satisfactory.
Reducing Debt: TSPC's debt to equity ratio has increased from 2% to 10.3% over the past 5 years.
Debt Coverage: TSPC's debt is well covered by operating cash flow (149.1%).
Interest Coverage: TSPC earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Tempo Scan Pacific current dividend yield, its reliability and sustainability?
3.27%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TSPC's dividend (3.27%) is higher than the bottom 25% of dividend payers in the ID market (1.14%).
High Dividend: TSPC's dividend (3.27%) is low compared to the top 25% of dividend payers in the ID market (4.92%).
Stability and Growth of Payments
Stable Dividend: TSPC's dividend payments have been volatile in the past 10 years.
Growing Dividend: TSPC's dividend payments have fallen over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (28.6%), TSPC's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.3yrs
Average board tenure
CEO
Diana Wirawan (64 yo)
1.33yrs
Tenure
Ms. Diana Wirawan serves as President Director PT Tempo Scan Pacific TBK since 2020. Ms. Wirawan had been Vice President Director of PT Tempo Scan Pacific TBK from 2012 until 2020 and has been its Director...
Board Members
Experienced Board: TSPC's board of directors are considered experienced (4.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
PT Tempo Scan Pacific Tbk's company bio, employee growth, exchange listings and data sources
Key Information
- Name: PT Tempo Scan Pacific Tbk
- Ticker: TSPC
- Exchange: IDX
- Founded: 1970
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: Rp6.885t
- Shares outstanding: 4.50b
- Website: https://www.thetempogroup.net
Number of Employees
Location
- PT Tempo Scan Pacific Tbk
- Tempo Scan Tower
- 16th Floor
- Jakarta
- Jakarta Raya
- 12950
- Indonesia
Listings
Biography
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. It operates through three segments: Pharmaceuti...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/05/09 17:07 |
| End of Day Share Price | 2021/05/07 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.